Life Science Law Update – Key developments for pharma & device companies in EU and EU Big Five – Technologist
Life Sciences Regulatory European Union Pharmaceuticals: The EMA’s and HMA’s strategy for AI: On 18 December 2023, the European Medicines Agency (EMA) and the Heads of Medicines Agencies (HMA) released a strategic plan for artificial intelligence (AI) until 2028. The strategic plan outlines a united approach to optimize AI advantages for stakeholders and address … Read more